Everyone Healthy Library
Pancreatic Cancer
Also Known As: Pancreatic Carcinoma
Condition / disease reference page from the Everyone Healthy database.
Connected health information
Explore this condition in a clear order
Condition overview
Attributes
Linked signs and symptoms
19Each sign/symptom opens its own page and links back to related conditions.
- Abdominal Mass
- Abdominal Pain Which Radiates Around to the Back
- Appetite Loss (Anorexia)
- Blood: Calcium Levels Raised (Hypercalcaemia, Hypercalcemia)
- Diarrhoea (Diarrhea)
- Fatigue
- Fluid Collection in Abdominal Cavity (Ascites)
- Indigestion (Dyspepsia)
- Mind: Depression
- Nausea
- Pain Abdominal
- Pain Back
- Pain in Upper Abdomen (Epigastric Burning)
- Skin Yellowing (Jaundice)
- Skin: Pale, Lack of Colour (Pallid Complexion)
- Stool Pale
- Vomiting
- Weakness
- Weight Loss (Body Mass Index Decreased)
Linked drugs / medications
5Medication information is educational only. A doctor or pharmacist should advise whether any medicine is appropriate.
Treatments, therapies and supportive options
22Grouped by treatment type. These are educational database links, not personal treatment recommendations. Evidence labels are shown only where stored in the EH database.
Surgery
3Endoscopic procedures
2Medical therapy
7- Bypass SurgeryWeakly in Favour(Low Evidence)
- ChemotherapyWeakly in Favour(Low Evidence)
- Distal PancreatectomyWeakly in Favour(Low Evidence)
- Endoscopic Retrograde Cholangiopancreatography (ERCP)Weakly in Favour(Low Evidence)
- Endoscopic Tumour ResectionWeakly in Favour(Low Evidence)
- Radiation TreatmentWeakly in Favour(Low Evidence)
- Whipple ProcedureWeakly in Favour(Low Evidence)
Alternative and complementary therapies
2Alternative medicine
1Vitamins and minerals
4Minerals
1Linked diagnostic tests and investigations
52These are pulled from both EH diagnostic-test link tables, including the older large test-link table.
- Activated Partial Thromboplastin Time (APTT)
- Alkaline Phosphatase (ALP) Concentration
- Alpha-1 Antitrypsin (AAT) Concentration
- Alpha-Fetoprotein (AFP, Serum AFP, Blood)
- amylase concentration
- Antithrombin 111 (AT-111) Activity Test
- Biopsy
- Blood Human Chorionic Gonadotropin (hCG) Test
- Blood Uric Acid Concentration Test
- C-Peptide Concentration Test
- Calcitonin (Thyrocalcitonin) Concentration
- Cerebrospinal Fluid Glucose Concentration
- Cerebrospinal Fluid Protein Concentration
- Cerebrospinal Fluid White Cell Differential
- Computerized Tomography (CT) Scan
- Endoscopic Retrograde Cholangiopancreatography (ERCP)
- Endoscopic Ultrasound (EUS)
- erythrocyte Sedimentation Rate (ESR)
- Euglobulin Lysis Time (Fibrinolysis Time)
- Fecal Chymotrypsin Concentration
- Fecal Fat Determination (Fat Absorption Test, Fecal Fat Stain)
- Fibrin Degradation Products (FDPs, Fibrin Split Products, FSPs, Fibrin Breakdown Products, Fbps)
- Fibrin Monomers Test
- Fibrinopeptide A (FPA) Action Assay
- Fluorescein Angiography
- Folic Acid (Folate) Concentration
- Gamma-Glutamyltransferase (GGT) Concentration
- Glucagon Concentration Test
- Glucose Tolerance Test (GTT, OGTT, 120 Minutes After Glucose Load)
- Glucose Tolerance Test (GTT, OGTT, 160 Minutes After Glucose Load)
- Glucose Tolerance Test (GTT, OGTT, 30 Minutes After Glucose Load)
- Glucose Tolerance Test (GTT, OGTT, 60 Minutes After Glucose Load)
- Glucose Tolerance Test (GTT, OGTT, Fasting Glucose)
- Glucose Tolerance Test for Gestational Diabetes (Fasting Glucose Value)
- Glucose, Blood (Fasting Blood Glucose)
- Glucose, Blood (Random Blood Glucose Test)
- haptoglobin (Hp) concentration
- Joint Fluid Analysis
- Low Density Lipoprotein (LDL) Concentration
- magnetic Resonance Angiogram (MRA)
- Pelvic Exam
- Potassium Concentration (K, Blood)
- Protein Electrophoresis (Blood, Serum Protein)
- Prothrombin Time (PT)
- Thyroid Stimulating Horomone (TSH) Concentration
- Thyroxine (Total T4) Concentration
- Triiodothyronine (Free T3) Concentration
- Triiodothyronine (Total T3) Concentration
- Triiodothyronine Uptake Test
- Ultrasound
- Urine Amylase Excretion Rate
- Vitamin B12 (VB12) Concentration
Biological and test markers
36This visual map uses existing EH database links to show biological agents and lab markers reported as increased, decreased, or associated with this condition. These are educational relationships only; test results must be interpreted by a qualified clinician because ranges vary by lab, method, age, sex and clinical context.
Often increased
20- Alkaline Phosphatase (ALP)Reference range exampleAdult ( > 16y), Female: 30–125 units/L; Adult ( > 16y), Male: 40–110 units/LLinked diagnostic tests1Alkaline Phosphatase (ALP) Concentration
- Alpha-1 Antintrypsin (AAT)Reference range exampleAdult ( > 16y): 90–215 mg/dLLinked diagnostic tests1Alpha-1 Antitrypsin (AAT) Concentration
- Alpha-Fetoprotein (Non-Pregnant, Serum)Reference range exampleAll: 5–40 ng/mLLinked diagnostic tests1Alpha-Fetoprotein (AFP, Serum AFP
- C-PeptideReference range exampleAdult ( > 16y): 0.5–2.7 ng/mLLinked diagnostic tests1C-Peptide Concentration Test
- Calcitonin (CT)Reference range exampleAll, Female: 0–14 pg/mL; All, Male: 0–19 pg/mLLinked diagnostic tests1Calcitonin (Thyrocalcitonin) Concentration
- Cerebrospinal Fluid LeukocytesReference range exampleAdult ( > 16y): 0–5 /µL; 1y - 6y: 0–20 /µLLinked diagnostic tests1Cerebrospinal Fluid White Cell Differential
- Cerebrospinal Fluid Neutrophil DifferentialReference range exampleAll: 0–5 %Linked diagnostic tests1Cerebrospinal Fluid White Cell Differential
- Cerebrospinal Fluid Total ProteinReference range exampleAdult ( > 16y): 15–45 mg/dL; Child (< 10y): 15–70 mg/dLLinked diagnostic tests1Cerebrospinal Fluid Protein Concentration
- Erythrocyte Sedimentation RateReference range exampleAdult ( > 16y), Female: 0–20 mm/Hr; Adult ( > 16y), Male: 0–15 mm/HrLinked diagnostic tests1erythrocyte Sedimentation Rate (ESR)
- Fecal FatReference range exampleAll: 1,000–7,000 mg/24hrsLinked diagnostic tests1Fecal Fat Determination (Fat Absorption Test, Fecal Fat Stain)
- Fibrin MonomersReference range example0–10,000 µg/LLinked diagnostic tests1Fibrin Monomers Test
- Fibrin Split ProductsReference range exampleAll: 0–1 mg/dLLinked diagnostic tests1Fibrin Degradation Products (FDPs, Fibrin Split Products
- Fibrinopeptide A (FPA)Reference range exampleAdult ( > 16y), Female: 0.7–3.1 mg/mL; Adult ( > 16y), Male: 0.35–2.5 mg/mLLinked diagnostic tests1Fibrinopeptide A (FPA) Action Assay
- Gamma Globulin (Blood, Serum)Reference range exampleAll: 0.8–1.7 gm/dLLinked diagnostic tests1Protein Electrophoresis (Blood, Serum Protein)
- Gamma-Glutamyltransferase (GGT)Reference range exampleAdult ( > 16y), Female: 6–30 units/L; Adult ( > 16y), Male: 6–38 units/LLinked diagnostic tests1Gamma-Glutamyltransferase (GGT) Concentration
- haptoglobin (Hp)Reference range example45–200 mg/dLLinked diagnostic tests1haptoglobin (Hp) concentration
- Human Chorionic Gonadotropin (Blood hCG)Reference range exampleAdult ( > 16y): 0–5 units/LLinked diagnostic tests1Blood Human Chorionic Gonadotropin (hCG) Test
- Prothrombin TimeReference range exampleAdult ( > 16y): 10–13 secondsLinked diagnostic tests1Prothrombin Time (PT)
- Thyroid Stimulating Horomone (TSH)Reference range exampleAdult ( > 16y): 0.021–0.11 µg/dL; Newborn (0 - 1month): 0.04–0.19 µg/dLLinked diagnostic tests2Thyroid Stimulating Horomone (TSH) Concentration, Urine B2 Microglobulin Concentration
- Uric Acid, BloodReference range exampleAdult ( > 16y), Female: 2.5–7 mg/dL; Adult ( > 16y), Male: 4–8 mg/dLLinked diagnostic tests1Blood Uric Acid Concentration Test
Often decreased
16- AmylaseReference range exampleAdult ( > 16y): 25–125 units/LLinked diagnostic tests1amylase concentration
- Antithrombin 111 (AT-111)Reference range exampleAdult ( > 16y): 90–110 %Linked diagnostic tests1Antithrombin 111 (AT-111) Activity Test
- Fecal ChymotrypsinReference range exampleAll: 75–1,200Linked diagnostic tests1Fecal Chymotrypsin Concentration
- Folic Acid (Folate)Reference range exampleInfant (0 - 1y): 14–51 ng/mL; Child (0 - 16y): 5–21 ng/mLLinked diagnostic tests1Folic Acid (Folate) Concentration
- GlucagonReference range exampleChild (0 - 16y): 0–147 pg/mL; Adult ( > 16y): 20–110 pg/mLLinked diagnostic tests1Glucagon Concentration Test
- Glucose (Blood)Reference range exampleInfant (0 - 1y): 3–6.1 mmol/L; Adult ( > 16y): 0–6.1 mmol/LLinked diagnostic tests11fasting Blood Glucose Test, Glucose Tolerance Test (GTT
- Glucose (Cerebrospinal Fluid)Reference range exampleChild (0 - 16y): 65–85 mg/dL; Adult ( > 16y): 50–72 mg/dLLinked diagnostic tests1Cerebrospinal Fluid Glucose Concentration
- Low Density Lipoprotein (LDL)Reference range exampleAdult ( > 16y): 0–125 mg/dL; 6y - 16y: 0–100 mg/dLLinked diagnostic tests1Low Density Lipoprotein (LDL) Concentration
- Plasma Clot Lysis TimeReference range exampleAll: 120–600 MinutesLinked diagnostic tests1Euglobulin Lysis Time (Fibrinolysis Time)
- Plasma thromboplastin antecedentReference range exampleAdult ( > 16y): 20–35 secondsLinked diagnostic tests1Activated Partial Thromboplastin Time (APTT)
- Potassium (K, Blood)AbbreviationKReference range exampleInfant (0 - 1y): 4.1–5.3 mEq/L; Child (0 - 16y): 3.4–4.7 mEq/LLinked diagnostic tests1Potassium Concentration (K, Blood)
- Thyroxine (Total T4)Reference range exampleAdult ( > 16y), Female: 6–12 µg/dL; Adult ( > 16y), Male: 5–12 µg/dLLinked diagnostic tests1Thyroxine (Total T4) Concentration
- Triiodothyronine (Total T3)Reference range exampleInfant (0 - 1y): 1.1–2.43 ng/mL; Adult ( > 16y): 1–2.1 ng/mLLinked diagnostic tests1Triiodothyronine (Total T3) Concentration
- Triiodothyronine Uptake PercentageReference range exampleAll: 25–38 %Linked diagnostic tests1Triiodothyronine Uptake Test
- Urine AmylaseReference range exampleAdult ( > 16y): 400–6,700 nkat/dayLinked diagnostic tests1Urine Amylase Excretion Rate
- Vitamin B12 (VB12)Reference range exampleAdult ( > 16y): 130–670 pmol/LLinked diagnostic tests1Vitamin B12 (VB12) Concentration
Other associated markers
0No markers in this group.
Introduction / full article
Pancreatic Cancer
Efficacy of Alternative and Other Treatments According to GRADE* Ranking:
Selenium Supplement [7, 15, 16, 17, 18, 19, 20, 21, 22, 23]:
Please note, this management does NOT treat the condition itself. It may mildly help with some of the symptoms, and even then has insufficient evidence to back up this claim at present. IMPORTANT: Selenium is toxic in high doses. Massive overdoses can cause kidney failure, breathing difficulty and death. Selenium should only be taken at healthy levels which the body is able to tolerate.
Recommendation: Weakly in favor (Observational studies have shown that taking adequate daily amounts of selenium can help prevent pancreatic cancer. However, these are very unreliable studies, and more research is needed.)
Grade of Evidence: very low of evidence
* www.gradeworkinggroup.org
Kampo [7, 13, 14]:
Please note, this management does NOT treat the condition itself. It may mildly help with some of the symptoms, and even then has insufficient evidence to back up this claim at present.
Recommendation: Weakly in favor (Initial studies indicate a possible slowing of cancer growth in pancreatic cancer when using Kampo. However, more studies are needed, and the side effects of the treatment are relatively unknown.)
Grade of Evidence: moderate quality of evidence
Green Tea [7, 8, 9, 10, 11, 12]:
Please note, this management does NOT treat the condition itself. It may mildly help with some of the symptoms, and even then has insufficient evidence to back up this claim at present.
Recommendation: Weakly in favor (Laboratory studies have shown promise with regards to the prevention of pancreatic cancer with green tea, but very few reliable clinical trials have been done. More research is needed.)
Grade of Evidence: low quality of evidence
Calcium Gluconate:
Please note, this management does NOT treat the condition itself. It is proposed only as a preventative or supportive management, not as a treatment.
Recommendation: weakly in favor (Calcium supplements have been shown to be effective in reducing the risk of pancreatic cancer)
Grade of Evidence: moderate quality of evidence
Calcium Supplements:
Please note, this management does NOT treat the condition itself. It is proposed only as a preventative or supportive management, not as a treatment.
Recommendation: weakly in favor (Calcium supplements have been shown to be effective in reducing the risk of pancreatic cancer)
Grade of Evidence: moderate quality of evidence
* www.gradeworkinggroup.org
Summary References
Treatments:
1. "FDA approval briefing"
2. Demols A, Peeters M, Polus M, et al. (February 2006). "Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study". British Journal of Cancer 94 (4): 481–5. doi:10.1038/sj.bjc.6602966
3. "Surgical Treatment of Pancreatic Cancer". Johns Hopkins University. http://pathology.jhu.edu/pancreas/TreatmentSurgery.php. Retrieved 5 September 2009.
4. Neoptolemos JP, Stocken DD, Friess H, et al. (March 2004). "A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer". The New England Journal of Medicine 350 (12): 1200–10. doi:10.1056/NEJMoa032295
5. Philip Agop, "Pancreatic Cancer". ACP PIER & AHFX DI Essentials. American College of Physicians. 4 Apr 2008. Accessed 7 Apr 2009.
6. http://www.merck.com/mmpe/sec02/ch021/ch021i.html?qt=cancer&alt=sh#sec02-ch021-ch021g-1550a
7. Ades T, Alteri R, Gansler T, Yeargin P, "Complete Guide to Complimentary & Alternative Cancer Therapies", American Cancer Society, Atlanta USA, 2009
8. http://www.cancer.org/Treatment/TreatmentsandSideEffects/ComplementaryandAlternativeMedicine/HerbsVitaminsandMinerals/green-tea
9. http://www.ncbi.nlm.nih.gov/pubmed/16968850
10. http://www.denverpost.com/nationworld/ci_4326770
11. http://www.nlm.nih.gov/medlineplus/druginfo/natural/patient-green_tea.html
12. http://nccam.nih.gov/health/greentea/index.htm
13. Shibata, Yoshiharu and Jean Wu. "Kampo Treatment for Climacteric Disorders: A Handbook for Practitioners." Paradigm Publications, 1997
14. http://www.cancer.org/Treatment/TreatmentsandSideEffects/ComplementaryandAlternativeMedicine/HerbsVitaminsandMinerals/kampo
15. http://www.cancer.org/Treatment/TreatmentsandSideEffects/ComplementaryandAlternativeMedicine/HerbsVitaminsandMinerals/selenium?sitearea=ETO
16. http://www.cancer.gov/Templates/doc.aspx?viewid=ED8AD8E8-6AE5-458D-8091-393F4CB73F0D
17. http://www.nlm.nih.gov/medlineplus/druginfo/natural/patient-selenium.html
18. http://www.ncbi.nlm.nih.gov/pubmed/9290116
19. http://www.ncbi.nlm.nih.gov/pubmed/9829869
20. http://www.ncbi.nlm.nih.gov/pubmed/10335455
21. http://www.ncbi.nlm.nih.gov/pubmed/2136228
22. http://www.springerlink.com/content/v0r644v4ju5153k2/
23. http://jnci.oxfordjournals.org/cgi/content/full/101/5/283